Beijing Scitop Bio Tech Co Ltd Total Liabilities
Beijing Scitop Bio Tech Co Ltd total liabilities. Based on the latest financial reports, Beijing Scitop Bio Tech Co Ltd (300858) has total liabilities worth CN¥236.16 Million CNY (≈ $34.56 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Beijing Scitop Bio Tech Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Beijing Scitop Bio Tech Co Ltd (2015–2025)
Total liabilities of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. This chart illustrates how Beijing Scitop Bio Tech Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Beijing Scitop Bio Tech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Scitop Bio Tech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
|
China | CN¥236.14 Million |
|
Shenzhen Prince New Materials Co Ltd
SHE:002735
|
China | CN¥1.49 Billion |
|
Shenzhen Jasic Tech Co
SHE:300193
|
China | CN¥1.01 Billion |
|
Fujian Raynen Tech Co Ltd
SHG:603933
|
China | CN¥1.63 Billion |
|
Aris Water Solutions Inc
NYSE:ARIS
|
USA | $689.21 Million |
|
Guangdong Xiongsu Technology Group Co Ltd
SHE:300599
|
China | CN¥277.13 Million |
|
Zhejiang Zoenn Design Co Ltd
SHE:300901
|
China | CN¥437.90 Million |
|
Bahnhof AB Series B
ST:BAHN-B
|
Sweden | Skr864.36 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Beijing Scitop Bio Tech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300858 asset base.
Liquidity & Leverage Metrics
Beijing Scitop Bio Tech Co Ltd Total Liabilities Ratios Explained
Beijing Scitop Bio Tech Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Scitop Bio Tech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Scitop Bio Tech Co Ltd (2015–2025)
The table below shows the annual total liabilities of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥176.08 Million ≈ $25.77 Million |
+39.71% |
| 2024-12-31 | CN¥126.03 Million ≈ $18.44 Million |
+63.46% |
| 2023-12-31 | CN¥77.10 Million ≈ $11.28 Million |
-17.97% |
| 2022-12-31 | CN¥93.99 Million ≈ $13.75 Million |
+28.17% |
| 2021-12-31 | CN¥73.33 Million ≈ $10.73 Million |
+10.01% |
| 2020-12-31 | CN¥66.66 Million ≈ $9.75 Million |
+0.78% |
| 2019-12-31 | CN¥66.14 Million ≈ $9.68 Million |
-8.02% |
| 2018-12-31 | CN¥71.91 Million ≈ $10.52 Million |
+27.71% |
| 2017-12-31 | CN¥56.30 Million ≈ $8.24 Million |
-21.46% |
| 2016-12-31 | CN¥71.69 Million ≈ $10.49 Million |
-45.64% |
| 2015-12-31 | CN¥131.89 Million ≈ $19.30 Million |
-- |
About Beijing Scitop Bio Tech Co Ltd
Beijing Scitop Bio-tech Co., Ltd. engages in the research, development, production, and sale of probiotic, postbiotics, and microecological preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women's health, slimming and fat reduction, kidney and liver protection, blood sugar … Read more